DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
EHC logo

Encompass Health Corporation Stock Price

NYSE:EHC Community·US$12.1b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

EHC Share Price Performance

US$121.75
-2.31 (-1.86%)
​
US$148.17
Fair Value
US$121.75
-2.31 (-1.86%)
17.8% undervalued intrinsic discount
US$148.17
Fair Value
Price US$121.75
AnalystConsensusTarget US$148.17
yiannisz US$99.17
Sat, 22 Aug 26
Fair ValueUS$148.17
Share Pricen/a

EHC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$148.17 17.8% undervalued intrinsic discount

EHC: Expanding Hospital Footprint And Bed Upgrades Will Shape Measured Outlook

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
YI
yiannisz's
Fair Value
·
Fair Value US$99.17 22.8% overvalued intrinsic discount

Encompass Health (EHC): Why Long-Term Recovery Models Are Becoming a Competitive Advantage

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
EHC logo
Encompass Health
22.8% overvalued intrinsic discount

Encompass Health (EHC): Why Long-Term Recovery Models Are Becoming a Competitive Advantage

View narrative
YI
yiannisz
Updated 2 Feb
Read Narrative
EHC logo
Encompass Health
17.8% undervalued intrinsic discount

EHC: Expanding Hospital Footprint And Bed Upgrades Will Shape Measured Outlook

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 22 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

YI
EHC logo

Encompass Health (EHC): Why Long-Term Recovery Models Are Becoming a Competitive Advantage

Fair Value: US$99.17 22.8% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
EHC logo

EHC: Capacity Expansion And Discharge Momentum Will Support Future Upside

Fair Value: US$148.17 17.8% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with proven track record.

2 Risks
4 Rewards
View Full Analysis

Encompass Health Corporation Key Details

US$6.2b

Revenue

US$3.5b

Cost of Revenue

US$2.7b

Gross Profit

US$2.1b

Other Expenses

US$603.7m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
6.12
43.86%
9.73%
68.0%
View Full Analysis

About EHC

Founded
1984
Employees
29699
CEO
Mark Tarr
WebsiteView website
www.encompasshealth.com

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Recent EHC News & Updates

User avatar
Narrative Update • Aug 22

EHC: Capacity Expansion And Discharge Momentum Will Support Future Upside

Analysts lifted their fair value estimate for Encompass Health to about $148.17 from $145.25, citing higher price targets near $150, recent Q2 revenue and adjusted EBITDA upside, raised FY26 guidance, stronger discharge trends, capacity expansion, and supportive industry conditions. Analyst Commentary Recent research on Encompass Health highlights a generally constructive view, with several firms lifting price targets and pointing to the latest Q2 results and updated guidance as key inputs to their valuation work.

Recent updates

No updates

Encompass Health Corporation Competitors

HCA logo

HCA Healthcare

Symbol: NYSE:HCA
Market cap: US$92.9b
ELV logo

Elevance Health

Symbol: NYSE:ELV
Market cap: US$89.8b
CI logo

Cigna Group

Symbol: NYSE:CI
Market cap: US$72.9b
BSX logo

Boston Scientific

Symbol: NYSE:BSX
Market cap: US$63.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide